vs
BGSF, INC.（BGSF）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
BGSF, INC.的季度营收约是SUTRO BIOPHARMA, INC.的1.9倍（$22.0M vs $11.6M），BGSF, INC.同比增速更快（-9.4% vs -21.4%），过去两年BGSF, INC.的营收复合增速更高（-5.3% vs -5.4%）
BGSF Inc.是一家总部位于美国的领先人力资源解决方案提供商，提供定制化人员派遣、人才招聘和全流程劳动力管理服务，覆盖信息技术、医疗健康、专业行政、轻工业、创意产业等核心领域，服务北美各规模的企业客户。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
BGSF vs STRO — 直观对比
营收规模更大
BGSF
是对方的1.9倍
$11.6M
营收增速更快
BGSF
高出12.0%
-21.4%
两年增速更快
BGSF
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.0M | $11.6M |
| 净利润 | $-1.2M | — |
| 毛利率 | 35.0% | — |
| 营业利润率 | -17.6% | — |
| 净利率 | -5.3% | — |
| 营收同比 | -9.4% | -21.4% |
| 净利润同比 | -18.2% | 35.4% |
| 每股收益（稀释后） | $-0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGSFSTRO
| Q4 25 | $22.0M | $11.6M | ||
| Q3 25 | $26.9M | $9.7M | ||
| Q2 25 | $23.5M | $63.7M | ||
| Q1 25 | $20.9M | $17.4M | ||
| Q4 24 | $24.3M | $14.8M | ||
| Q3 24 | $29.8M | $8.5M | ||
| Q2 24 | $25.7M | $25.7M | ||
| Q1 24 | $24.5M | $13.0M |
净利润BGSFSTRO
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-5.8M | $-56.9M | ||
| Q2 25 | $-3.7M | $-11.5M | ||
| Q1 25 | $-722.0K | $-76.0M | ||
| Q4 24 | $-981.0K | $-72.4M | ||
| Q3 24 | $-804.0K | $-48.8M | ||
| Q2 24 | $-761.0K | $-48.0M | ||
| Q1 24 | $-792.0K | $-58.2M |
毛利率BGSFSTRO
| Q4 25 | 35.0% | — | ||
| Q3 25 | 35.9% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 36.2% | — | ||
| Q4 24 | 35.9% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 38.1% | — |
营业利润率BGSFSTRO
| Q4 25 | -17.6% | — | ||
| Q3 25 | -3.5% | -499.9% | ||
| Q2 25 | -18.8% | -5.2% | ||
| Q1 25 | 1.6% | -393.8% | ||
| Q4 24 | -15.7% | -440.7% | ||
| Q3 24 | -3.4% | -797.2% | ||
| Q2 24 | -5.7% | -189.4% | ||
| Q1 24 | 1.7% | -435.0% |
净利率BGSFSTRO
| Q4 25 | -5.3% | — | ||
| Q3 25 | -21.6% | -586.6% | ||
| Q2 25 | -15.9% | -18.0% | ||
| Q1 25 | -3.5% | -436.6% | ||
| Q4 24 | -4.0% | -489.2% | ||
| Q3 24 | -2.7% | -572.6% | ||
| Q2 24 | -3.0% | -186.8% | ||
| Q1 24 | -3.2% | -447.5% |
每股收益（稀释后）BGSFSTRO
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-0.52 | $-0.67 | ||
| Q2 25 | $-0.34 | $-0.14 | ||
| Q1 25 | $-0.06 | $-0.91 | ||
| Q4 24 | — | $-27.63 | ||
| Q3 24 | $-0.07 | $-0.59 | ||
| Q2 24 | $-0.07 | $-0.59 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.1M | $-132.5M |
| 总资产 | $57.8M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BGSFSTRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | $41.2M | $167.6M | ||
| Q2 25 | $2.8M | $205.1M | ||
| Q1 25 | $2.0M | $249.0M | ||
| Q4 24 | $32.0K | $316.9M | ||
| Q3 24 | $262 | $388.3M | ||
| Q2 24 | $226 | $375.6M | ||
| Q1 24 | $50 | $267.6M |
股东权益BGSFSTRO
| Q4 25 | $48.1M | $-132.5M | ||
| Q3 25 | $50.7M | $-87.3M | ||
| Q2 25 | $78.3M | $-32.1M | ||
| Q1 25 | $81.8M | $-25.8M | ||
| Q4 24 | $82.3M | $44.6M | ||
| Q3 24 | $82.9M | $111.2M | ||
| Q2 24 | $83.2M | $152.2M | ||
| Q1 24 | $83.6M | $98.0M |
总资产BGSFSTRO
| Q4 25 | $57.8M | $173.8M | ||
| Q3 25 | $83.6M | $209.7M | ||
| Q2 25 | $149.7M | $262.4M | ||
| Q1 25 | $152.3M | $321.4M | ||
| Q4 24 | $150.1M | $387.2M | ||
| Q3 24 | $157.3K | $451.8M | ||
| Q2 24 | $159.8K | $489.0M | ||
| Q1 24 | $170.6K | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $1.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-16.0K | — |
8季度趋势，按日历期对齐
经营现金流BGSFSTRO
| Q4 25 | $1.7M | $-177.2M | ||
| Q3 25 | $-4.8M | $-38.2M | ||
| Q2 25 | $2.2M | $-44.7M | ||
| Q1 25 | $1.1M | $-67.9M | ||
| Q4 24 | $3.2M | $-71.7M | ||
| Q3 24 | $6.5M | $-64.5M | ||
| Q2 24 | $7.3M | $9.5M | ||
| Q1 24 | $7.4M | $-64.7M |
自由现金流BGSFSTRO
| Q4 25 | $1.7M | — | ||
| Q3 25 | $-4.9M | — | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $6.9M | — |
自由现金流率BGSFSTRO
| Q4 25 | 7.6% | — | ||
| Q3 25 | -18.1% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 21.7% | — | ||
| Q2 24 | 28.5% | — | ||
| Q1 24 | 28.1% | — |
资本支出强度BGSFSTRO
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.0% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
STRO
暂无分部数据
